nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR2A—hindlimb—muscle cancer	0.00439	0.0666	CbGeAlD
Pergolide—HTR2A—appendage—muscle cancer	0.00377	0.0571	CbGeAlD
Pergolide—DRD4—testis—muscle cancer	0.00312	0.0473	CbGeAlD
Pergolide—ADRA1B—renal system—muscle cancer	0.00261	0.0395	CbGeAlD
Pergolide—DRD3—head—muscle cancer	0.00227	0.0344	CbGeAlD
Pergolide—DRD5—head—muscle cancer	0.00213	0.0323	CbGeAlD
Pergolide—HTR2B—smooth muscle tissue—muscle cancer	0.00184	0.0279	CbGeAlD
Pergolide—ADRA1B—head—muscle cancer	0.00175	0.0264	CbGeAlD
Pergolide—ADRA1D—head—muscle cancer	0.00171	0.0259	CbGeAlD
Pergolide—DRD1—head—muscle cancer	0.00163	0.0246	CbGeAlD
Pergolide—HTR1A—renal system—muscle cancer	0.00159	0.0241	CbGeAlD
Pergolide—Alopecia—Etoposide—muscle cancer	0.0015	0.00161	CcSEcCtD
Pergolide—Cerebrovascular accident—Methotrexate—muscle cancer	0.0015	0.0016	CcSEcCtD
Pergolide—Lymphadenopathy—Doxorubicin—muscle cancer	0.00149	0.0016	CcSEcCtD
Pergolide—Oedema—Vincristine—muscle cancer	0.00149	0.00159	CcSEcCtD
Pergolide—Infection—Vincristine—muscle cancer	0.00148	0.00158	CcSEcCtD
Pergolide—Thrombophlebitis—Doxorubicin—muscle cancer	0.00147	0.00157	CcSEcCtD
Pergolide—ADRA1A—renal system—muscle cancer	0.00147	0.0222	CbGeAlD
Pergolide—Diabetes mellitus—Doxorubicin—muscle cancer	0.00146	0.00157	CcSEcCtD
Pergolide—Thrombocytopenia—Vincristine—muscle cancer	0.00146	0.00156	CcSEcCtD
Pergolide—Decreased appetite—Dactinomycin—muscle cancer	0.00145	0.00155	CcSEcCtD
Pergolide—Dysgeusia—Etoposide—muscle cancer	0.00145	0.00155	CcSEcCtD
Pergolide—Hyperhidrosis—Vincristine—muscle cancer	0.00144	0.00154	CcSEcCtD
Pergolide—Back pain—Etoposide—muscle cancer	0.00143	0.00153	CcSEcCtD
Pergolide—Pain—Dactinomycin—muscle cancer	0.00142	0.00152	CcSEcCtD
Pergolide—Vascular purpura—Doxorubicin—muscle cancer	0.00142	0.00152	CcSEcCtD
Pergolide—Anorexia—Vincristine—muscle cancer	0.00142	0.00152	CcSEcCtD
Pergolide—KCNH2—renal system—muscle cancer	0.00142	0.0214	CbGeAlD
Pergolide—Eczema—Doxorubicin—muscle cancer	0.00142	0.00152	CcSEcCtD
Pergolide—Eye pain—Doxorubicin—muscle cancer	0.00141	0.00151	CcSEcCtD
Pergolide—Cardiac failure congestive—Doxorubicin—muscle cancer	0.0014	0.0015	CcSEcCtD
Pergolide—ADRA2C—renal system—muscle cancer	0.0014	0.0212	CbGeAlD
Pergolide—Mood swings—Methotrexate—muscle cancer	0.00139	0.00149	CcSEcCtD
Pergolide—Hypotension—Vincristine—muscle cancer	0.00139	0.00149	CcSEcCtD
Pergolide—HTR2B—tendon—muscle cancer	0.00138	0.021	CbGeAlD
Pergolide—Ataxia—Methotrexate—muscle cancer	0.00138	0.00148	CcSEcCtD
Pergolide—Feeling abnormal—Dactinomycin—muscle cancer	0.00137	0.00147	CcSEcCtD
Pergolide—Ill-defined disorder—Etoposide—muscle cancer	0.00137	0.00147	CcSEcCtD
Pergolide—Anaemia—Etoposide—muscle cancer	0.00136	0.00146	CcSEcCtD
Pergolide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00136	0.00146	CcSEcCtD
Pergolide—Liver function test abnormal—Methotrexate—muscle cancer	0.00136	0.00145	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00136	0.00145	CcSEcCtD
Pergolide—Increased appetite—Doxorubicin—muscle cancer	0.00135	0.00145	CcSEcCtD
Pergolide—Insomnia—Vincristine—muscle cancer	0.00135	0.00144	CcSEcCtD
Pergolide—Paraesthesia—Vincristine—muscle cancer	0.00134	0.00143	CcSEcCtD
Pergolide—Malaise—Etoposide—muscle cancer	0.00133	0.00143	CcSEcCtD
Pergolide—Dermatitis bullous—Doxorubicin—muscle cancer	0.00133	0.00142	CcSEcCtD
Pergolide—Vertigo—Etoposide—muscle cancer	0.00133	0.00142	CcSEcCtD
Pergolide—Leukopenia—Etoposide—muscle cancer	0.00132	0.00142	CcSEcCtD
Pergolide—Purpura—Doxorubicin—muscle cancer	0.00132	0.00141	CcSEcCtD
Pergolide—HTR1B—head—muscle cancer	0.00132	0.02	CbGeAlD
Pergolide—Body temperature increased—Dactinomycin—muscle cancer	0.00132	0.00141	CcSEcCtD
Pergolide—Abdominal pain—Dactinomycin—muscle cancer	0.00132	0.00141	CcSEcCtD
Pergolide—Hypoglycaemia—Doxorubicin—muscle cancer	0.0013	0.0014	CcSEcCtD
Pergolide—Loss of consciousness—Etoposide—muscle cancer	0.0013	0.00139	CcSEcCtD
Pergolide—Cerebrovascular accident—Doxorubicin—muscle cancer	0.0013	0.00139	CcSEcCtD
Pergolide—Decreased appetite—Vincristine—muscle cancer	0.00129	0.00138	CcSEcCtD
Pergolide—Cough—Etoposide—muscle cancer	0.00129	0.00138	CcSEcCtD
Pergolide—HTR2B—vagina—muscle cancer	0.00129	0.0195	CbGeAlD
Pergolide—Convulsion—Etoposide—muscle cancer	0.00128	0.00137	CcSEcCtD
Pergolide—HTR1D—head—muscle cancer	0.00128	0.0193	CbGeAlD
Pergolide—Hypertension—Etoposide—muscle cancer	0.00128	0.00137	CcSEcCtD
Pergolide—Constipation—Vincristine—muscle cancer	0.00127	0.00136	CcSEcCtD
Pergolide—Pain—Vincristine—muscle cancer	0.00127	0.00136	CcSEcCtD
Pergolide—Diplopia—Doxorubicin—muscle cancer	0.00127	0.00136	CcSEcCtD
Pergolide—Asthma—Methotrexate—muscle cancer	0.00127	0.00136	CcSEcCtD
Pergolide—KCNH2—cardiac atrium—muscle cancer	0.00127	0.0192	CbGeAlD
Pergolide—HTR2C—head—muscle cancer	0.00126	0.0191	CbGeAlD
Pergolide—Chest pain—Etoposide—muscle cancer	0.00126	0.00135	CcSEcCtD
Pergolide—Eosinophilia—Methotrexate—muscle cancer	0.00126	0.00135	CcSEcCtD
Pergolide—Affect lability—Doxorubicin—muscle cancer	0.00125	0.00134	CcSEcCtD
Pergolide—Migraine—Doxorubicin—muscle cancer	0.00125	0.00134	CcSEcCtD
Pergolide—HTR2A—embryo—muscle cancer	0.00125	0.019	CbGeAlD
Pergolide—ADRA2C—cardiac atrium—muscle cancer	0.00125	0.0189	CbGeAlD
Pergolide—Pancreatitis—Methotrexate—muscle cancer	0.00124	0.00133	CcSEcCtD
Pergolide—Discomfort—Etoposide—muscle cancer	0.00124	0.00133	CcSEcCtD
Pergolide—Face oedema—Doxorubicin—muscle cancer	0.00123	0.00131	CcSEcCtD
Pergolide—Gastrointestinal pain—Vincristine—muscle cancer	0.00122	0.0013	CcSEcCtD
Pergolide—Confusional state—Etoposide—muscle cancer	0.00122	0.0013	CcSEcCtD
Pergolide—Cardiac arrest—Doxorubicin—muscle cancer	0.00121	0.00129	CcSEcCtD
Pergolide—Mood swings—Doxorubicin—muscle cancer	0.0012	0.00129	CcSEcCtD
Pergolide—Infection—Etoposide—muscle cancer	0.0012	0.00128	CcSEcCtD
Pergolide—Ataxia—Doxorubicin—muscle cancer	0.0012	0.00128	CcSEcCtD
Pergolide—Asthenia—Dactinomycin—muscle cancer	0.00119	0.00128	CcSEcCtD
Pergolide—HTR2B—head—muscle cancer	0.00119	0.018	CbGeAlD
Pergolide—Dysuria—Methotrexate—muscle cancer	0.00119	0.00127	CcSEcCtD
Pergolide—Dehydration—Doxorubicin—muscle cancer	0.00118	0.00127	CcSEcCtD
Pergolide—Thrombocytopenia—Etoposide—muscle cancer	0.00118	0.00126	CcSEcCtD
Pergolide—Tachycardia—Etoposide—muscle cancer	0.00118	0.00126	CcSEcCtD
Pergolide—Body temperature increased—Vincristine—muscle cancer	0.00118	0.00126	CcSEcCtD
Pergolide—Abdominal pain—Vincristine—muscle cancer	0.00118	0.00126	CcSEcCtD
Pergolide—Liver function test abnormal—Doxorubicin—muscle cancer	0.00117	0.00126	CcSEcCtD
Pergolide—Erectile dysfunction—Methotrexate—muscle cancer	0.00117	0.00125	CcSEcCtD
Pergolide—Dry skin—Doxorubicin—muscle cancer	0.00117	0.00125	CcSEcCtD
Pergolide—Hyperhidrosis—Etoposide—muscle cancer	0.00117	0.00125	CcSEcCtD
Pergolide—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00116	0.00124	CcSEcCtD
Pergolide—Hypokalaemia—Doxorubicin—muscle cancer	0.00116	0.00124	CcSEcCtD
Pergolide—Anorexia—Etoposide—muscle cancer	0.00115	0.00123	CcSEcCtD
Pergolide—Diarrhoea—Dactinomycin—muscle cancer	0.00114	0.00122	CcSEcCtD
Pergolide—Pneumonia—Methotrexate—muscle cancer	0.00114	0.00122	CcSEcCtD
Pergolide—Depression—Methotrexate—muscle cancer	0.00113	0.00121	CcSEcCtD
Pergolide—Hypotension—Etoposide—muscle cancer	0.00113	0.00121	CcSEcCtD
Pergolide—Gastritis—Doxorubicin—muscle cancer	0.00113	0.00121	CcSEcCtD
Pergolide—Renal failure—Methotrexate—muscle cancer	0.00111	0.00119	CcSEcCtD
Pergolide—Abdominal distension—Doxorubicin—muscle cancer	0.00111	0.00118	CcSEcCtD
Pergolide—Conjunctivitis—Methotrexate—muscle cancer	0.0011	0.00118	CcSEcCtD
Pergolide—Influenza—Doxorubicin—muscle cancer	0.0011	0.00118	CcSEcCtD
Pergolide—Asthma—Doxorubicin—muscle cancer	0.0011	0.00118	CcSEcCtD
Pergolide—Dysphagia—Doxorubicin—muscle cancer	0.0011	0.00118	CcSEcCtD
Pergolide—ADRA2C—tendon—muscle cancer	0.00109	0.0165	CbGeAlD
Pergolide—Eosinophilia—Doxorubicin—muscle cancer	0.00109	0.00117	CcSEcCtD
Pergolide—Sweating—Methotrexate—muscle cancer	0.00109	0.00116	CcSEcCtD
Pergolide—Paraesthesia—Etoposide—muscle cancer	0.00108	0.00116	CcSEcCtD
Pergolide—Haematuria—Methotrexate—muscle cancer	0.00108	0.00116	CcSEcCtD
Pergolide—Pancreatitis—Doxorubicin—muscle cancer	0.00108	0.00115	CcSEcCtD
Pergolide—Dyspnoea—Etoposide—muscle cancer	0.00107	0.00115	CcSEcCtD
Pergolide—Somnolence—Etoposide—muscle cancer	0.00107	0.00115	CcSEcCtD
Pergolide—Angina pectoris—Doxorubicin—muscle cancer	0.00107	0.00115	CcSEcCtD
Pergolide—KCNH2—bone marrow—muscle cancer	0.00107	0.0162	CbGeAlD
Pergolide—Epistaxis—Methotrexate—muscle cancer	0.00107	0.00114	CcSEcCtD
Pergolide—Asthenia—Vincristine—muscle cancer	0.00107	0.00114	CcSEcCtD
Pergolide—HTR1A—head—muscle cancer	0.00106	0.0161	CbGeAlD
Pergolide—Vomiting—Dactinomycin—muscle cancer	0.00106	0.00113	CcSEcCtD
Pergolide—Bronchitis—Doxorubicin—muscle cancer	0.00106	0.00113	CcSEcCtD
Pergolide—Rash—Dactinomycin—muscle cancer	0.00105	0.00112	CcSEcCtD
Pergolide—Decreased appetite—Etoposide—muscle cancer	0.00105	0.00112	CcSEcCtD
Pergolide—Pain—Etoposide—muscle cancer	0.00103	0.0011	CcSEcCtD
Pergolide—Constipation—Etoposide—muscle cancer	0.00103	0.0011	CcSEcCtD
Pergolide—Dysuria—Doxorubicin—muscle cancer	0.00103	0.0011	CcSEcCtD
Pergolide—KCNH2—vagina—muscle cancer	0.00103	0.0155	CbGeAlD
Pergolide—Diarrhoea—Vincristine—muscle cancer	0.00102	0.00109	CcSEcCtD
Pergolide—Hepatitis—Methotrexate—muscle cancer	0.00102	0.00109	CcSEcCtD
Pergolide—Pollakiuria—Doxorubicin—muscle cancer	0.00102	0.00109	CcSEcCtD
Pergolide—ADRA2C—vagina—muscle cancer	0.00101	0.0153	CbGeAlD
Pergolide—Pharyngitis—Methotrexate—muscle cancer	0.00101	0.00108	CcSEcCtD
Pergolide—Weight increased—Doxorubicin—muscle cancer	0.001	0.00107	CcSEcCtD
Pergolide—ADRA2A—cardiac atrium—muscle cancer	0.000998	0.0151	CbGeAlD
Pergolide—Weight decreased—Doxorubicin—muscle cancer	0.000995	0.00106	CcSEcCtD
Pergolide—Feeling abnormal—Etoposide—muscle cancer	0.000993	0.00106	CcSEcCtD
Pergolide—Hyperglycaemia—Doxorubicin—muscle cancer	0.000992	0.00106	CcSEcCtD
Pergolide—Nausea—Dactinomycin—muscle cancer	0.000989	0.00106	CcSEcCtD
Pergolide—Pneumonia—Doxorubicin—muscle cancer	0.000986	0.00106	CcSEcCtD
Pergolide—Gastrointestinal pain—Etoposide—muscle cancer	0.000986	0.00106	CcSEcCtD
Pergolide—HTR2A—smooth muscle tissue—muscle cancer	0.000984	0.0149	CbGeAlD
Pergolide—Dizziness—Vincristine—muscle cancer	0.000984	0.00105	CcSEcCtD
Pergolide—ADRA1A—head—muscle cancer	0.000981	0.0149	CbGeAlD
Pergolide—Visual impairment—Methotrexate—muscle cancer	0.000979	0.00105	CcSEcCtD
Pergolide—Renal failure—Doxorubicin—muscle cancer	0.000963	0.00103	CcSEcCtD
Pergolide—DRD2—head—muscle cancer	0.000961	0.0146	CbGeAlD
Pergolide—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000961	0.00103	CcSEcCtD
Pergolide—Jaundice—Doxorubicin—muscle cancer	0.000955	0.00102	CcSEcCtD
Pergolide—Abdominal pain—Etoposide—muscle cancer	0.000953	0.00102	CcSEcCtD
Pergolide—Body temperature increased—Etoposide—muscle cancer	0.000953	0.00102	CcSEcCtD
Pergolide—Conjunctivitis—Doxorubicin—muscle cancer	0.000953	0.00102	CcSEcCtD
Pergolide—Urinary tract infection—Doxorubicin—muscle cancer	0.000953	0.00102	CcSEcCtD
Pergolide—Eye disorder—Methotrexate—muscle cancer	0.00095	0.00102	CcSEcCtD
Pergolide—HTR2A—renal system—muscle cancer	0.000948	0.0144	CbGeAlD
Pergolide—Tinnitus—Methotrexate—muscle cancer	0.000947	0.00101	CcSEcCtD
Pergolide—KCNH2—head—muscle cancer	0.000947	0.0143	CbGeAlD
Pergolide—Vomiting—Vincristine—muscle cancer	0.000946	0.00101	CcSEcCtD
Pergolide—Sweating—Doxorubicin—muscle cancer	0.00094	0.00101	CcSEcCtD
Pergolide—Rash—Vincristine—muscle cancer	0.000938	0.001	CcSEcCtD
Pergolide—Dermatitis—Vincristine—muscle cancer	0.000937	0.001	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—muscle cancer	0.000935	0.001	CcSEcCtD
Pergolide—ADRA2C—head—muscle cancer	0.000934	0.0142	CbGeAlD
Pergolide—Headache—Vincristine—muscle cancer	0.000932	0.000998	CcSEcCtD
Pergolide—DRD2—testis—muscle cancer	0.000928	0.0141	CbGeAlD
Pergolide—Epistaxis—Doxorubicin—muscle cancer	0.000924	0.00099	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—muscle cancer	0.00092	0.000985	CcSEcCtD
Pergolide—KCNH2—testis—muscle cancer	0.000915	0.0139	CbGeAlD
Pergolide—Chills—Methotrexate—muscle cancer	0.000912	0.000976	CcSEcCtD
Pergolide—ADRA2C—testis—muscle cancer	0.000903	0.0137	CbGeAlD
Pergolide—Alopecia—Methotrexate—muscle cancer	0.000898	0.000961	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—muscle cancer	0.000896	0.000959	CcSEcCtD
Pergolide—Nausea—Vincristine—muscle cancer	0.000884	0.000946	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—muscle cancer	0.000882	0.000944	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—muscle cancer	0.00088	0.000942	CcSEcCtD
Pergolide—CYP3A4—renal system—muscle cancer	0.000877	0.0133	CbGeAlD
Pergolide—Pharyngitis—Doxorubicin—muscle cancer	0.000873	0.000935	CcSEcCtD
Pergolide—ADRA2A—tendon—muscle cancer	0.00087	0.0132	CbGeAlD
Pergolide—Oedema peripheral—Doxorubicin—muscle cancer	0.000867	0.000928	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—muscle cancer	0.000866	0.000927	CcSEcCtD
Pergolide—Asthenia—Etoposide—muscle cancer	0.000865	0.000926	CcSEcCtD
Pergolide—CYP2D6—renal system—muscle cancer	0.000863	0.0131	CbGeAlD
Pergolide—Back pain—Methotrexate—muscle cancer	0.000856	0.000916	CcSEcCtD
Pergolide—Pruritus—Etoposide—muscle cancer	0.000853	0.000913	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—muscle cancer	0.000848	0.000908	CcSEcCtD
Pergolide—Diarrhoea—Etoposide—muscle cancer	0.000825	0.000883	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—muscle cancer	0.000822	0.00088	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—muscle cancer	0.000821	0.000879	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—muscle cancer	0.00082	0.000878	CcSEcCtD
Pergolide—Anaemia—Methotrexate—muscle cancer	0.000818	0.000875	CcSEcCtD
Pergolide—ADRA2A—vagina—muscle cancer	0.000807	0.0122	CbGeAlD
Pergolide—Malaise—Methotrexate—muscle cancer	0.000798	0.000854	CcSEcCtD
Pergolide—Dizziness—Etoposide—muscle cancer	0.000797	0.000853	CcSEcCtD
Pergolide—Vertigo—Methotrexate—muscle cancer	0.000795	0.000851	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—muscle cancer	0.000792	0.000848	CcSEcCtD
Pergolide—Chills—Doxorubicin—muscle cancer	0.000789	0.000845	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—muscle cancer	0.000786	0.000842	CcSEcCtD
Pergolide—Alopecia—Doxorubicin—muscle cancer	0.000778	0.000832	CcSEcCtD
Pergolide—Cough—Methotrexate—muscle cancer	0.000772	0.000826	CcSEcCtD
Pergolide—Convulsion—Methotrexate—muscle cancer	0.000766	0.000821	CcSEcCtD
Pergolide—Vomiting—Etoposide—muscle cancer	0.000766	0.00082	CcSEcCtD
Pergolide—Rash—Etoposide—muscle cancer	0.00076	0.000814	CcSEcCtD
Pergolide—Dermatitis—Etoposide—muscle cancer	0.000759	0.000813	CcSEcCtD
Pergolide—Headache—Etoposide—muscle cancer	0.000755	0.000808	CcSEcCtD
Pergolide—Flatulence—Doxorubicin—muscle cancer	0.000755	0.000808	CcSEcCtD
Pergolide—Chest pain—Methotrexate—muscle cancer	0.000753	0.000806	CcSEcCtD
Pergolide—Myalgia—Methotrexate—muscle cancer	0.000753	0.000806	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—muscle cancer	0.000753	0.000806	CcSEcCtD
Pergolide—Tension—Doxorubicin—muscle cancer	0.000752	0.000805	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—muscle cancer	0.00075	0.000803	CcSEcCtD
Pergolide—ADRA2A—head—muscle cancer	0.000746	0.0113	CbGeAlD
Pergolide—Discomfort—Methotrexate—muscle cancer	0.000744	0.000797	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—muscle cancer	0.000744	0.000797	CcSEcCtD
Pergolide—Back pain—Doxorubicin—muscle cancer	0.000741	0.000793	CcSEcCtD
Pergolide—HTR2A—tendon—muscle cancer	0.00074	0.0112	CbGeAlD
Pergolide—Confusional state—Methotrexate—muscle cancer	0.000728	0.000779	CcSEcCtD
Pergolide—ADRA2A—testis—muscle cancer	0.00072	0.0109	CbGeAlD
Pergolide—Infection—Methotrexate—muscle cancer	0.000717	0.000768	CcSEcCtD
Pergolide—Nausea—Etoposide—muscle cancer	0.000716	0.000767	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—muscle cancer	0.000711	0.000761	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—muscle cancer	0.000708	0.000758	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—muscle cancer	0.000707	0.000757	CcSEcCtD
Pergolide—Agitation—Doxorubicin—muscle cancer	0.000704	0.000754	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—muscle cancer	0.000698	0.000747	CcSEcCtD
Pergolide—Malaise—Doxorubicin—muscle cancer	0.000691	0.00074	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—muscle cancer	0.000688	0.000737	CcSEcCtD
Pergolide—Anorexia—Methotrexate—muscle cancer	0.000688	0.000737	CcSEcCtD
Pergolide—Syncope—Doxorubicin—muscle cancer	0.000687	0.000735	CcSEcCtD
Pergolide—HTR2A—vagina—muscle cancer	0.000686	0.0104	CbGeAlD
Pergolide—Leukopenia—Doxorubicin—muscle cancer	0.000686	0.000734	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—muscle cancer	0.000677	0.000725	CcSEcCtD
Pergolide—Hypotension—Methotrexate—muscle cancer	0.000675	0.000722	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—muscle cancer	0.000673	0.000721	CcSEcCtD
Pergolide—Cough—Doxorubicin—muscle cancer	0.000668	0.000716	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—muscle cancer	0.000664	0.000711	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—muscle cancer	0.000661	0.000708	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000658	0.000704	CcSEcCtD
Pergolide—Insomnia—Methotrexate—muscle cancer	0.000653	0.000699	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—muscle cancer	0.000652	0.000698	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—muscle cancer	0.000652	0.000698	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—muscle cancer	0.000652	0.000698	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—muscle cancer	0.00065	0.000696	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—muscle cancer	0.000648	0.000694	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—muscle cancer	0.000644	0.00069	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—muscle cancer	0.000644	0.000689	CcSEcCtD
Pergolide—Somnolence—Methotrexate—muscle cancer	0.000642	0.000687	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—muscle cancer	0.000638	0.000683	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—muscle cancer	0.000635	0.00068	CcSEcCtD
Pergolide—HTR2A—head—muscle cancer	0.000634	0.0096	CbGeAlD
Pergolide—Confusional state—Doxorubicin—muscle cancer	0.00063	0.000675	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—muscle cancer	0.000628	0.000672	CcSEcCtD
Pergolide—Oedema—Doxorubicin—muscle cancer	0.000625	0.000669	CcSEcCtD
Pergolide—Infection—Doxorubicin—muscle cancer	0.000621	0.000665	CcSEcCtD
Pergolide—Pain—Methotrexate—muscle cancer	0.000617	0.000661	CcSEcCtD
Pergolide—Shock—Doxorubicin—muscle cancer	0.000615	0.000658	CcSEcCtD
Pergolide—HTR2A—testis—muscle cancer	0.000612	0.00928	CbGeAlD
Pergolide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000612	0.000655	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—muscle cancer	0.00061	0.000653	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000604	0.000647	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—muscle cancer	0.000596	0.000638	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—muscle cancer	0.000595	0.000637	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00059	0.000632	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—muscle cancer	0.000584	0.000625	CcSEcCtD
Pergolide—CYP2D6—head—muscle cancer	0.000578	0.00875	CbGeAlD
Pergolide—Abdominal pain—Methotrexate—muscle cancer	0.000571	0.000611	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—muscle cancer	0.000571	0.000611	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00057	0.00061	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—muscle cancer	0.000565	0.000605	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—muscle cancer	0.000561	0.000601	CcSEcCtD
Pergolide—CYP2D6—testis—muscle cancer	0.000558	0.00845	CbGeAlD
Pergolide—Dyspnoea—Doxorubicin—muscle cancer	0.000557	0.000597	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—muscle cancer	0.000556	0.000595	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—muscle cancer	0.00055	0.000589	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—muscle cancer	0.000543	0.000582	CcSEcCtD
Pergolide—Constipation—Doxorubicin—muscle cancer	0.000535	0.000572	CcSEcCtD
Pergolide—Pain—Doxorubicin—muscle cancer	0.000535	0.000572	CcSEcCtD
Pergolide—Asthenia—Methotrexate—muscle cancer	0.000518	0.000555	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—muscle cancer	0.000515	0.000552	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000511	0.000547	CcSEcCtD
Pergolide—Pruritus—Methotrexate—muscle cancer	0.000511	0.000547	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—muscle cancer	0.000494	0.000529	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—muscle cancer	0.000494	0.000529	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—muscle cancer	0.000494	0.000529	CcSEcCtD
Pergolide—Dizziness—Methotrexate—muscle cancer	0.000477	0.000511	CcSEcCtD
Pergolide—Vomiting—Methotrexate—muscle cancer	0.000459	0.000491	CcSEcCtD
Pergolide—Rash—Methotrexate—muscle cancer	0.000455	0.000487	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—muscle cancer	0.000455	0.000487	CcSEcCtD
Pergolide—Headache—Methotrexate—muscle cancer	0.000452	0.000484	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—muscle cancer	0.000449	0.00048	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—muscle cancer	0.000442	0.000474	CcSEcCtD
Pergolide—Nausea—Methotrexate—muscle cancer	0.000429	0.000459	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—muscle cancer	0.000428	0.000458	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—muscle cancer	0.000413	0.000443	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—muscle cancer	0.000397	0.000426	CcSEcCtD
Pergolide—Rash—Doxorubicin—muscle cancer	0.000394	0.000422	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—muscle cancer	0.000394	0.000422	CcSEcCtD
Pergolide—Headache—Doxorubicin—muscle cancer	0.000392	0.000419	CcSEcCtD
Pergolide—Nausea—Doxorubicin—muscle cancer	0.000371	0.000398	CcSEcCtD
